Asset Management Ventures

SeeQC develops application-specific quantum computing systems using superconducting qubits. It serves industries such as machine learning/AI, logistics optimization, quantum chemistry, pharmaceuticals, and fintech globally. Founded in 2018, SeeQC is headquartered in Elmsford, New York with facilities in London, UK, and Naples, Italy.

Medsien is a provider of remote care management services that utilizes artificial intelligence to enhance patient engagement and health outcomes. The company has developed a platform that integrates various care management programs, allowing healthcare providers to efficiently monitor chronic conditions and manage remote patient care. By curating and aggregating patient data, Medsien's technology delivers insights into patient health trends and metrics, enabling real-time notifications of any changes. This streamlined approach not only improves the patient experience but also helps reduce costs and supports informed decision-making for healthcare providers.

Endless Health is a digital platform dedicated to cardiovascular health management. It offers evidence-based information on heart conditions and prevention strategies, along with remote consultations via video chat or messaging with certified healthcare professionals. Users can track their health data and goals through an intuitive dashboard.

Basys.ai streamlines healthcare administration by automating prior authorization and utilization management processes for health plans using an AI-based platform. This proprietary system digitizes payer policies via machine learning, reducing implementation timelines significantly.

Autonomize AI specializes in developing advanced AI copilots for the healthcare sector. These tools organize, contextualize, and summarize unstructured data, enabling swift data-driven decisions and enhancing patient outcomes. As a founding member of CancerX, a US President Biden's Cancer Moonshot initiative, Autonomize AI is at the forefront of cancer research innovation. They serve top pharmaceutical companies, payors, and life sciences firms.

SubjectWell is a clinical trial marketplace focused on patient recruitment, providing a risk-free platform for healthcare clients to efficiently find and screen qualified participants for clinical trials. By streamlining the recruitment process, SubjectWell helps accelerate the completion of studies, ensuring that healthcare organizations can meet their research timelines effectively. The company specializes in delivering highly qualified referrals, thereby enhancing the overall efficiency of clinical trials and contributing to advancements in medical research.

Array Insights is an IT firm focused on developing artificial intelligence-driven solutions aimed at managing patient and caregiver narratives. The company offers a clinical data registry platform that enables the secure sharing of sensitive healthcare data while maintaining ownership and compliance. By employing advanced encryption techniques, Array Insights connects data algorithms to facilitate the analysis and training of AI models without compromising security or privacy. This platform allows hospitals and healthcare providers to effectively control, track, and trace patient information, thereby enhancing research capabilities and accelerating the pace of innovation in the healthcare sector. Founded in 2017 and based in Cambridge, Massachusetts, Array Insights is dedicated to improving data accessibility while safeguarding proprietary and sensitive information.

Carta Healthcare provides a software-as-a-service platform that maps the patient journey through hospitals by integrating data from existing information systems. The platform identifies potential bottlenecks weeks in advance and issues alerts about bed shortages and cancellations. It enables hospitals to personalize care by analyzing past patient journeys and using machine learning to predict what the current patient will need and what to expect during treatment. Its clinical data abstraction capabilities automate extraction and processing to improve efficiency, accuracy, and compliance. The solution supports hospitals and research organizations in optimizing patient care, resource allocation, and operational decisions. Founded in 2016 and based in San Mateo, California, Carta Healthcare focuses on turning disparate clinical data into actionable insights to improve care delivery.

LegalMate is a technology company that aims to enhance access to legal services. It offers a platform designed to automate complex legal processes, allowing law firms to manage payment plans efficiently while adhering to IOLTA and ABA guidelines. This enables more clients to afford professional legal representation tailored to their specific needs.

Pluto Health is a technology company that builds a care coordination platform for patients and providers. The platform aggregates electronic health record data from multiple health systems, pharmacies, and laboratories, and automatically extracts insights to support personalized care plans. It offers remote monitoring tools, communication channels between patients and clinicians, and reminders for tasks such as medication adherence, bill payments, and data sharing. By integrating diverse health data and providing proactive coordination, the platform helps patients fill care gaps and access tailored clinical support.

Founded in 2017, Outcomes4Me is a Boston-based company that empowers cancer patients through its AI-driven platform. This platform provides personalized, evidence-based treatment options and real-time clinical information, enabling patients to navigate their care effectively and improve outcomes.

Carta Healthcare provides a software-as-a-service platform that maps the patient journey through hospitals by integrating data from existing information systems. The platform identifies potential bottlenecks weeks in advance and issues alerts about bed shortages and cancellations. It enables hospitals to personalize care by analyzing past patient journeys and using machine learning to predict what the current patient will need and what to expect during treatment. Its clinical data abstraction capabilities automate extraction and processing to improve efficiency, accuracy, and compliance. The solution supports hospitals and research organizations in optimizing patient care, resource allocation, and operational decisions. Founded in 2016 and based in San Mateo, California, Carta Healthcare focuses on turning disparate clinical data into actionable insights to improve care delivery.

Array Insights is an IT firm focused on developing artificial intelligence-driven solutions aimed at managing patient and caregiver narratives. The company offers a clinical data registry platform that enables the secure sharing of sensitive healthcare data while maintaining ownership and compliance. By employing advanced encryption techniques, Array Insights connects data algorithms to facilitate the analysis and training of AI models without compromising security or privacy. This platform allows hospitals and healthcare providers to effectively control, track, and trace patient information, thereby enhancing research capabilities and accelerating the pace of innovation in the healthcare sector. Founded in 2017 and based in Cambridge, Massachusetts, Array Insights is dedicated to improving data accessibility while safeguarding proprietary and sensitive information.

Founded in 2017, Outcomes4Me is a Boston-based company that empowers cancer patients through its AI-driven platform. This platform provides personalized, evidence-based treatment options and real-time clinical information, enabling patients to navigate their care effectively and improve outcomes.

Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, focused on drug discovery through innovative technology. Founded in 2016, the company specializes in designing and developing a platform that utilizes artificial intelligence and computational biology techniques to create macrocyclic peptides. These peptides target intracellular protein interactions, addressing drug targets that are typically considered undruggable. By harnessing machine learning to optimize chemical synthesis, Unnatural Products aims to accelerate the drug discovery process, offering potential therapeutic strategies for a wide range of medical conditions. Through its unique approach, the company seeks to pioneer new treatments where traditional methods have fallen short.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

UniKey Technologies specializes in smart access control solutions. It offers a mobile platform that replaces traditional keys with smartphone-based electronic keys, featuring touch-to-open technology, intelligent detection of user location, and robust security measures. The company partners with lock manufacturers like Kwikset and Weiser to create smart locks such as Kevo, and provides cloud-based lock management for multifamily properties and commercial businesses.

Founded in 2013, Welkin Health develops software that guides healthcare teams through patient management workflows. Its platform ensures patients receive care at the right time by configuring care programs into actionable tasks for health workers. Welkin's software facilitates communication between providers, health plans, and patients via phone, text, video, and email.

Mightier is a Boston-based company that develops bioresponsive video games and a family program designed to help children regulate emotions. The platform pairs gameplay with a biofeedback heart rate monitor to adjust game difficulty, encouraging kids to stay calm and in control while learning to recognize and manage emotions in daily life. Created through collaboration with Boston Children's Hospital and Harvard Medical School, Mightier aims to address behavioral and emotional challenges by teaching real-time emotion regulation skills. Founded in 2016, the company offers a program that integrates mind-body signals into interactive experiences, enabling children to practice emotional control through engaging, age-appropriate games.

Signal Vine, Inc. is a technology company that specializes in developing an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. Founded in 2013 and headquartered in Alexandria, Virginia, the company offers a range of features including targeted messaging, an intuitive interface, case management, and comprehensive reporting and analytics. By utilizing a blended messaging approach, Signal Vine enables its clients—such as K-12 schools, higher education institutions, nonprofits, and government programs—to leverage student data to deliver personalized communications. This capability aims to improve student engagement by sending timely reminders and support messages about important deadlines and opportunities, ultimately fostering better enrollment and retention outcomes. Additionally, Signal Vine provides customer support services to assist users in maximizing the effectiveness of their messaging strategies.

Carta Healthcare provides a software-as-a-service platform that maps the patient journey through hospitals by integrating data from existing information systems. The platform identifies potential bottlenecks weeks in advance and issues alerts about bed shortages and cancellations. It enables hospitals to personalize care by analyzing past patient journeys and using machine learning to predict what the current patient will need and what to expect during treatment. Its clinical data abstraction capabilities automate extraction and processing to improve efficiency, accuracy, and compliance. The solution supports hospitals and research organizations in optimizing patient care, resource allocation, and operational decisions. Founded in 2016 and based in San Mateo, California, Carta Healthcare focuses on turning disparate clinical data into actionable insights to improve care delivery.

InCarda Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases. Founded in 2009 and based in Newark, California, the company specializes in a novel inhaled treatment approach to manage acute cardiovascular conditions. Its lead product, InRhythm, is an inhaled formulation of an antiarrhythmic drug designed to treat paroxysmal atrial fibrillation quickly, allowing patients to administer the therapy in various settings, such as at home or work. By delivering medication directly to cardiac tissue, InCarda's therapy aims to provide effective treatment for atrial arrhythmias with a simplified approach. The company has completed Phase 1 clinical trials and is currently advancing its lead product through Phase 2 trials.

Properly, Inc. is a technology company based in San Francisco, California, established in 2014. It offers a platform and mobile application designed to streamline operations related to vacation rental properties, including housekeeping and property maintenance. Properly serves a diverse clientele, including property owners, property managers, and service providers. The company's visual checklist tool facilitates effective communication between property owners and cleaning professionals, ensuring that turnover instructions are easily shared and understood. Properly aims to standardize the cleaning process for hosts and property managers while enhancing the recognition of professional cleaners for their quality work.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Founded in 2017, 3T Biosciences is a biotechnology company based in Menlo Park, California. It specializes in immunotherapies for cancer treatment.

Huiseoul is an e-commerce company based in Seoul, South Korea, specializing in the online retail of cosmetic products. It focuses on providing personalized skincare consultations and exclusively offers Korean beauty products to the Chinese market. The company has developed a comprehensive online platform that facilitates conversational e-commerce, where beauty consultants deliver detailed skincare advice in a user-friendly format. This platform includes various technological components such as front-end and back-end development, API integration, and mobile applications, all aimed at enhancing the customer experience in skincare shopping.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Signal Vine, Inc. is a technology company that specializes in developing an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. Founded in 2013 and headquartered in Alexandria, Virginia, the company offers a range of features including targeted messaging, an intuitive interface, case management, and comprehensive reporting and analytics. By utilizing a blended messaging approach, Signal Vine enables its clients—such as K-12 schools, higher education institutions, nonprofits, and government programs—to leverage student data to deliver personalized communications. This capability aims to improve student engagement by sending timely reminders and support messages about important deadlines and opportunities, ultimately fostering better enrollment and retention outcomes. Additionally, Signal Vine provides customer support services to assist users in maximizing the effectiveness of their messaging strategies.

Indi Molecular is a life sciences company based in Culver City, California, developing a fully synthetic class of diagnostic and therapeutic agents with antibody-like properties, known as protein-catalyzed capture agents (PCCs). PCCs are designed to replace traditional antibodies in in vivo imaging, therapeutics, and diagnostics, using a shared chelation chemistry platform that enables tailoring for therapeutic or PET imaging radionuclides. Produced via click chemistry, PCCs offer high selectivity, strong binding affinity, low molecular weight, and a fully synthetic composition compared with monoclonal antibodies. The company originated as a spinout from Integrated Diagnostics in 2013.

UniKey Technologies specializes in smart access control solutions. It offers a mobile platform that replaces traditional keys with smartphone-based electronic keys, featuring touch-to-open technology, intelligent detection of user location, and robust security measures. The company partners with lock manufacturers like Kwikset and Weiser to create smart locks such as Kevo, and provides cloud-based lock management for multifamily properties and commercial businesses.

Amygdala Neurosciences, Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to discovering, developing, and commercializing pharmacotherapies aimed at treating and preventing addiction. Incorporated in 2015, the company is focused on its lead product, ANS-6637, a selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor. This innovative compound is designed to prevent pathophysiologic dopamine surges that typically contribute to drug-seeking behavior, cravings, and relapse, without affecting baseline dopamine levels. Pre-clinical studies have shown that ANS-6637 effectively reduces self-administration and relapse in various models of substance use, including nicotine, alcohol, cocaine, heroin, and methamphetamine, and also exhibits anxiolytic properties. Having completed extensive Phase 1 studies, Amygdala Neurosciences is poised to initiate Phase 2 efficacy studies, with an initial focus on smoking cessation alongside parallel development for cocaine, opioid, and alcohol use disorders.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Founded in 2013, Twist Bioscience specializes in manufacturing and selling synthetic DNA-based products. Its innovative silicon-based DNA Synthesis Platform enables rapid, precise, high-throughput synthesis of DNA, serving customers in healthcare, agriculture, industrial chemicals, and data storage sectors.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Founded in 2013, Welkin Health develops software that guides healthcare teams through patient management workflows. Its platform ensures patients receive care at the right time by configuring care programs into actionable tasks for health workers. Welkin's software facilitates communication between providers, health plans, and patients via phone, text, video, and email.

Founded in 2017, 3T Biosciences is a biotechnology company based in Menlo Park, California. It specializes in immunotherapies for cancer treatment.

Womply is a local commerce platform founded in 2011 that aims to support the growth of small businesses in a digital environment. The company offers a range of applications, APIs, and marketing and financial tools designed to enhance local commerce for over 500,000 businesses across the United States. Womply's services are driven by its proprietary Womply Commerce Graph, a comprehensive data asset that provides insights into local commerce dynamics. The platform includes features for online presence and reputation management, as well as customer and revenue analytics, addressing the typical needs of local businesses. Through its technology and data-driven approach, Womply seeks to empower small businesses to thrive and simplify their operational challenges.

Founded in 2012, Mozio operates an online platform that aggregates and compares various airport ground transportation options worldwide. Its services include shared ride shuttles, private vans, taxis, limousines, and public transit. Mozio enables travelers to search and book these services through its user-friendly interface, facilitating seamless travel from airports to final destinations.

InCarda Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases. Founded in 2009 and based in Newark, California, the company specializes in a novel inhaled treatment approach to manage acute cardiovascular conditions. Its lead product, InRhythm, is an inhaled formulation of an antiarrhythmic drug designed to treat paroxysmal atrial fibrillation quickly, allowing patients to administer the therapy in various settings, such as at home or work. By delivering medication directly to cardiac tissue, InCarda's therapy aims to provide effective treatment for atrial arrhythmias with a simplified approach. The company has completed Phase 1 clinical trials and is currently advancing its lead product through Phase 2 trials.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

ViewPoint Therapeutics, founded in 2014 and headquartered in San Francisco, specializes in developing treatments for diseases caused by protein misfolding. Its primary focus is on age-related cataracts, a leading cause of blindness worldwide. The company's innovative approach involves creating crystallin stabilizers, including a small molecule active in preclinical models of cataracts. These stabilizers aim to prevent or reverse protein misfolding, which underlies various common disorders associated with aging. ViewPoint Therapeutics is committed to advancing its pipeline to deliver effective therapies for these conditions.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

SensOmics develops innovative medical wearable technology aimed at early detection of pediatric diseases. The company combines genomics with clinical informatics, electrical engineering, and artificial intelligence to enable healthcare professionals to diagnose and treat conditions more effectively.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

RallyPoint Networks, Inc. is an online networking platform dedicated to serving current and former U.S. military members, as well as their civilian supporters. Founded in 2012 and based in Watertown, Massachusetts, RallyPoint facilitates connections among its two million users, enabling them to build professional networks and explore career opportunities both within the military and in the private sector. The platform assists members in translating their military experiences for civilian employers, effectively bridging the gap between transitioning veterans and organizations seeking their skills. RallyPoint aims to support the military community in leading successful and fulfilling lives while providing employers with targeted tools to engage with this unique talent pool. The company operates as a subsidiary of Student Veterans of America.

WellDoc, Inc. is a healthcare technology company focused on chronic disease management, particularly diabetes. Founded in 2005 and headquartered in Baltimore, Maryland, with additional offices in Wilmington, Delaware, and Bengaluru, India, WellDoc develops innovative solutions that integrate into existing healthcare workflows. Its flagship platform, DiabetesManager, provides personalized, real-time coaching and support for patients and healthcare providers, facilitating self-management and adherence to treatment regimens. The platform features tools for medication reminders, alerts for out-of-range metrics, and cloud-based analytics for tracking health outcomes. Additionally, WellDoc offers BlueStar, a mobile prescription therapy solution that guides patients in managing their diabetes. The company serves various stakeholders in the healthcare ecosystem, including payors, employers, pharmaceutical companies, and medical device firms, and has established strategic partnerships to enhance its offerings.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Founded in 2013, Welkin Health develops software that guides healthcare teams through patient management workflows. Its platform ensures patients receive care at the right time by configuring care programs into actionable tasks for health workers. Welkin's software facilitates communication between providers, health plans, and patients via phone, text, video, and email.

Founded in 2013, Twist Bioscience specializes in manufacturing and selling synthetic DNA-based products. Its innovative silicon-based DNA Synthesis Platform enables rapid, precise, high-throughput synthesis of DNA, serving customers in healthcare, agriculture, industrial chemicals, and data storage sectors.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Amygdala Neurosciences, Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to discovering, developing, and commercializing pharmacotherapies aimed at treating and preventing addiction. Incorporated in 2015, the company is focused on its lead product, ANS-6637, a selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor. This innovative compound is designed to prevent pathophysiologic dopamine surges that typically contribute to drug-seeking behavior, cravings, and relapse, without affecting baseline dopamine levels. Pre-clinical studies have shown that ANS-6637 effectively reduces self-administration and relapse in various models of substance use, including nicotine, alcohol, cocaine, heroin, and methamphetamine, and also exhibits anxiolytic properties. Having completed extensive Phase 1 studies, Amygdala Neurosciences is poised to initiate Phase 2 efficacy studies, with an initial focus on smoking cessation alongside parallel development for cocaine, opioid, and alcohol use disorders.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.

Womply is a local commerce platform founded in 2011 that aims to support the growth of small businesses in a digital environment. The company offers a range of applications, APIs, and marketing and financial tools designed to enhance local commerce for over 500,000 businesses across the United States. Womply's services are driven by its proprietary Womply Commerce Graph, a comprehensive data asset that provides insights into local commerce dynamics. The platform includes features for online presence and reputation management, as well as customer and revenue analytics, addressing the typical needs of local businesses. Through its technology and data-driven approach, Womply seeks to empower small businesses to thrive and simplify their operational challenges.

LiquidM Technology, established in 2013, is a Berlin-based company that operates as a subsidiary of Smart AdServer SAS. It specializes in providing a single, intuitive platform for advertising and campaign management, primarily focused on mobile display media. The company's modular, cloud-based software enables agencies and trading desks to customize their ad tech infrastructure, offering greater efficiency, control, and insights into media planning and buying. LiquidM's platform is white-labeled, agnostic to third-party integrations, and supports real-time bidding, targeting, and inventory procurement.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

Signal Vine, Inc. is a technology company that specializes in developing an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. Founded in 2013 and headquartered in Alexandria, Virginia, the company offers a range of features including targeted messaging, an intuitive interface, case management, and comprehensive reporting and analytics. By utilizing a blended messaging approach, Signal Vine enables its clients—such as K-12 schools, higher education institutions, nonprofits, and government programs—to leverage student data to deliver personalized communications. This capability aims to improve student engagement by sending timely reminders and support messages about important deadlines and opportunities, ultimately fostering better enrollment and retention outcomes. Additionally, Signal Vine provides customer support services to assist users in maximizing the effectiveness of their messaging strategies.

Biomimedica is a medical device company based in South San Francisco, California, dedicated to innovating joint repair solutions through its proprietary synthetic cartilage technology. Founded in 2007, the company specializes in developing synthetic cartilages designed to restore the surface of damaged joints, providing effective medical devices for joint repair. Its pioneering approaches aim to enhance patient outcomes and advance the field of orthopedic medicine.

Benefitter Insurance Solutions, Inc. is a company that provides web-based tools designed to assist employers in managing employee health coverage. Incorporated in 2012 and based in San Francisco, California, it offers a range of solutions including ReformCommunicator, which generates required communications regarding healthcare options; ReformNavigator, which assists employees in selecting and enrolling in health insurance; ReformAdvisor, which helps determine the suitability of employer-sponsored coverage; and ReformReadiness, which gathers necessary data for employee census and insurance quoting. By enhancing the decision-making process for both employers and employees, Benefitter aims to simplify navigation through health care reform and improve overall employee well-being. As of August 2015, the company operates as a subsidiary of HealthMarkets Insurance Company.

Founded in 2013, Twist Bioscience specializes in manufacturing and selling synthetic DNA-based products. Its innovative silicon-based DNA Synthesis Platform enables rapid, precise, high-throughput synthesis of DNA, serving customers in healthcare, agriculture, industrial chemicals, and data storage sectors.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Founded in 2013, Twist Bioscience specializes in manufacturing and selling synthetic DNA-based products. Its innovative silicon-based DNA Synthesis Platform enables rapid, precise, high-throughput synthesis of DNA, serving customers in healthcare, agriculture, industrial chemicals, and data storage sectors.

Maverix Biomics, Inc. is a biotechnology company based in San Mateo, California, that offers a cloud-based platform tailored for biologists and life science researchers. Founded in 2010, the platform facilitates the management, analysis, and visualization of genomic data, addressing the needs of researchers in various domains, including RNA-seq, ChIP-seq, and methylation analysis. By integrating genomic data with biomic information across viral, bacterial, vertebrate, and plant genomes, Maverix Biomics aims to enhance research capabilities and foster collaborative discovery. The company leverages expertise from leading research institutions and technology firms, creating an open platform that combines advanced bioinformatics with user-friendly features to streamline complex data analytics. This approach not only accelerates scientific advancements but also helps overcome traditional research bottlenecks.

Womply is a local commerce platform founded in 2011 that aims to support the growth of small businesses in a digital environment. The company offers a range of applications, APIs, and marketing and financial tools designed to enhance local commerce for over 500,000 businesses across the United States. Womply's services are driven by its proprietary Womply Commerce Graph, a comprehensive data asset that provides insights into local commerce dynamics. The platform includes features for online presence and reputation management, as well as customer and revenue analytics, addressing the typical needs of local businesses. Through its technology and data-driven approach, Womply seeks to empower small businesses to thrive and simplify their operational challenges.

Indi Molecular is a life sciences company based in Culver City, California, developing a fully synthetic class of diagnostic and therapeutic agents with antibody-like properties, known as protein-catalyzed capture agents (PCCs). PCCs are designed to replace traditional antibodies in in vivo imaging, therapeutics, and diagnostics, using a shared chelation chemistry platform that enables tailoring for therapeutic or PET imaging radionuclides. Produced via click chemistry, PCCs offer high selectivity, strong binding affinity, low molecular weight, and a fully synthetic composition compared with monoclonal antibodies. The company originated as a spinout from Integrated Diagnostics in 2013.

RallyPoint Networks, Inc. is an online networking platform dedicated to serving current and former U.S. military members, as well as their civilian supporters. Founded in 2012 and based in Watertown, Massachusetts, RallyPoint facilitates connections among its two million users, enabling them to build professional networks and explore career opportunities both within the military and in the private sector. The platform assists members in translating their military experiences for civilian employers, effectively bridging the gap between transitioning veterans and organizations seeking their skills. RallyPoint aims to support the military community in leading successful and fulfilling lives while providing employers with targeted tools to engage with this unique talent pool. The company operates as a subsidiary of Student Veterans of America.

LiquidM Technology, established in 2013, is a Berlin-based company that operates as a subsidiary of Smart AdServer SAS. It specializes in providing a single, intuitive platform for advertising and campaign management, primarily focused on mobile display media. The company's modular, cloud-based software enables agencies and trading desks to customize their ad tech infrastructure, offering greater efficiency, control, and insights into media planning and buying. LiquidM's platform is white-labeled, agnostic to third-party integrations, and supports real-time bidding, targeting, and inventory procurement.

Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.

Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

Synecor LLC is a medical device company based in Durham, North Carolina, with additional locations in California and North Carolina. Founded in 2000 by Dr. Richard Stack, the company emerged from collaborative relationships in the field of interventional cardiology. Synecor specializes in developing innovative medical device technologies across various specialties, including obesity and spine therapeutics. The company focuses on creating minimally invasive device-based treatments, bioerodible vascular stent platforms for coronary artery disease, and solutions for managing arrhythmias. Additionally, Synecor is advancing a technology platform designed to access and treat the gastrointestinal system through natural orifices. By addressing unmet medical needs, Synecor aims to offer effective treatment options that enable patients to begin their care promptly, thereby improving the likelihood of successful outcomes.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

Proteus Digital Health is a digital medicines company that developed technology to integrate medicines with ingestible sensors, wearable devices, mobile applications, and cloud-based data systems. Its digital health feedback technology provided insights into medication adherence and physiological responses, helping patients manage their health and enabling collaboration among caregivers and clinicians. The company offered ingestible sensors, wearable patches, and analytics portals to monitor patients remotely, improve therapy adherence, and enhance clinical outcomes, with data analytics supporting physicians and health systems in decision making. Founded in 2001 and based in Redwood City, California, it was formerly known as Proteus Biomedical.

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

Biomimedica is a medical device company based in South San Francisco, California, dedicated to innovating joint repair solutions through its proprietary synthetic cartilage technology. Founded in 2007, the company specializes in developing synthetic cartilages designed to restore the surface of damaged joints, providing effective medical devices for joint repair. Its pioneering approaches aim to enhance patient outcomes and advance the field of orthopedic medicine.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Terra Bella is a private company based in Mountain View, California, specializing in high-resolution satellite imagery and analytics services. Originally founded as Skybox Imaging in 2009 by Dan Berkenstock, Julian Mann, John Fenwick, and Ching-Yu Hu, the company operates the SkySat-1 satellite, which captures detailed panchromatic and multispectral images of the Earth. Terra Bella focuses on analyzing the movement of goods and people, providing valuable visual data for various applications, including supply chain monitoring, shipping logistics, industrial plant activity, and humanitarian relief efforts. Through its advanced imaging technology, the company aims to deliver critical insights that support decision-making across multiple sectors.

Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

ICON Aircraft, Inc. is a manufacturer based in Vacaville, California, that specializes in designing, developing, and producing light consumer sport aircraft. Founded in 2004, the company aims to make personal flight more accessible through innovative and safe aircraft, including its flagship model, the A5. The A5 is an amphibious sport plane recognized for its advanced aeronautical engineering, unique design, and safety features, including being the world's first production aircraft that is spin-resistant. ICON Aircraft also operates an online store selling various aviation-related gear and apparel. The company's mission is to democratize personal flight and 3-D mobility, fostering a culture that encourages intelligent risk-taking and collaboration among its team members. With a commitment to delivering technologically advanced and consumer-friendly products, ICON Aircraft seeks to inspire a global community of aviation enthusiasts.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company specializing in the development of immune-based therapies for various cancers. The company is known for its innovative products, including ICT-107, a dendritic cell immunotherapy designed for newly diagnosed glioblastoma multiforme, a highly aggressive brain cancer. Additionally, ImmunoCellular is advancing ICT-140, which targets tumor-associated antigens in ovarian cancer, and ICT-121, aimed at treating recurrent glioblastoma and other solid tumors by targeting CD133 markers on cancer stem cells. The company also explores Steam-to-T-Cell immunotherapies to enhance cancer treatment. ImmunoCellular Therapeutics has established licensing agreements with prestigious institutions such as the California Institute of Technology and The Johns Hopkins University. Originally named Optical Molecular Imaging, Inc., the company rebranded in November 2006 and is headquartered in Westlake Village, California.

Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Ooma develops smart cloud-based software-as-a-service (SaaS) platforms for businesses and consumers worldwide. Its offerings include advanced voice and collaboration features, residential phone service with PureVoice HD quality, and a comprehensive home security solution.

Rapidscan Pharma Solutions, Inc. is a pharmaceutical company founded in 2010, specializing in the development, manufacture, and sale of a pharmacological stress agent known as Regadenoson. This agent is utilized in the diagnosis and risk stratification of cardiovascular disease, particularly for patients undergoing myocardial perfusion imaging procedures. Rapidscan has secured licensing rights to market Regadenoson across various regions, including Europe, Latin America, Japan, Australia, New Zealand, and Israel. With a significant patient population affected by coronary artery disease, the company addresses a critical need in cardiovascular diagnostics. Rapidscan operates as a subsidiary of GE Healthcare.

Provade, Inc. is a provider of enterprise vendor management systems focused on workforce management and procurement. Established in 2004 and headquartered in Milwaukee, Wisconsin, with additional offices in Pleasanton, California; Highworth, United Kingdom; and Sydney, Australia, the company serves medium to large enterprises across various sectors, including technology, finance, and manufacturing. Provade specializes in contingent workforce management and offers a suite of services such as identity management, implementation, training, support, and managed services. Its solutions are built around Oracle's enterprise platform, enabling organizations to improve efficiency, gain visibility, and achieve measurable savings in contingent labor and procurement processes. The company also provides subscription-based applications that integrate with existing financial and HR systems, along with professional services to enhance procurement strategies. As of early 2018, Provade operates as a subsidiary of Smart ERP Solutions Inc.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

OfferIQ specializes in providing paperless coupon services, focusing on delivering in-store shopping discounts directly to consumers' mobile phones. The company operates a Virtual Incentive Platform that links incentives to a consumer's debit or credit card, allowing these discounts to be redeemed seamlessly during the payment process. This approach eliminates the need for retailers to make any modifications at the point of sale or provide additional staff training.